Intranasal administration of neurotoxicants in animals: Support for the olfactory vector hypothesis of Parkinson's disease

Neurotoxicity Research

Volumn 21, Issue 1, 2012, Pages 90-116

  Prediger, Rui D S ^a   Aguiar Jr , Aderbal S ^a   Matheus, Filipe C ^a   Walz, Roger ^a   Antoury, Layal ^b   Raisman Vozari, Rita ^c   Doty, Richard L ^b  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Animal models; Intranasal; Neurotoxicants; Olfaction; Olfactory vector hypothesis; Parkinson's disease; Review

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALUMINUM; CADMIUM; CHROMIUM; IRON; LEAD; MANGANESE; MERCURY; NEUROTOXIN; OXIDOPAMINE; PARAQUAT; ROTENONE; XENOBIOTIC AGENT; ZINC;

DISEASE COURSE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; ENVIRONMENTAL EXPOSURE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPOTHESIS; INFLUENZA VIRUS; JAPANESE ENCEPHALITIS VIRUS; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OLFACTORY EPITHELIUM; OLFACTORY SYSTEM; OLFACTORY VECTOR HYPOTHESIS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SMELLING DISORDER; ST LOUIS FLAVIVIRUS; SUBSTANTIA NIGRA; WEST NILE FLAVIVIRUS;

ADMINISTRATION, INTRANASAL; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; METALS; MICE; NEUROTOXINS; OLFACTORY PATHWAYS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PESTICIDES; RATS; VIRUSES;

ANIMALIA; RODENTIA;

EID: 84856282425     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-011-9281-8     Document Type: Review

References (228)

1. Albanese A, Bentivoglio M (1982) The organization of dopaminergic and nondopaminergic mesencephalocortical neurons in the rat. Brain Res 238:421-425 (Pubitemid 12156253)
2. Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357-381 (Pubitemid 16055790)
3. Andersson T, Mohammed AK, Henriksson BG, Wickman C, Norrby E, Schultzberg M, Kristensson K (1993) Immunohistochemical and behaviour pharmacological analysis of rats inoculated intranasally with vesicular stomatitis virus. J Chem Neuroanat 6:7-18 (Pubitemid 23079408)
4. Ansari KA, Johnson A (1975) Olfactory function in patients with Parkinson's disease. J Chronic Dis 28:493-497
5. Antunes MB, Bowler R, Doty RL (2007) San-Francisco/Oakland Bay Bridge welder study: olfactory function. Neurology 69:1278-1284 (Pubitemid 47429029)
6. Aronsson F, Robertson B, Ljunggren H, Kristensson K (2003) Invasion and persistence of the neuroadapted influenza virus A/WSN/33 in the mouse olfactory system. Viral Immunol 16:415-423 (Pubitemid 37229552)
7. Baba T, Takeda A, Kikuchi A, Nishio Y, Hosokai Y, Hirayama K, Hasegawa T, Sugeno N, Suzuki K, Mori E, Takahashi S, Fukuda H, Itoyama Y (2011) Association of olfactory dysfunction and brain metabolism in Parkinson's disease. Mov Disord 26:621-628
8. Barbeau A (1984) Manganese and extrapyramidal disorders (a critical review and tribute to Dr George C Cotzias). Neurotoxicology 5:13-35
9. Barnett EM, Perlman S (1993) The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM. Virology 194:185-191
10. Barnett EM, Cassell MD, Perlman S (1993) Two neurotropic viruses, Herpes simplex virus type I and mouse hepatitis virus, spread along different neural pathways from the main olfactory bulb. Neuroscience 57:1007-1025 (Pubitemid 23355003)
11. Bazer G, Ebbesson S, Reynolds J, Bailey R (1987) A cobalt-lysine study of primary olfactory projections in king salmon fry (Oncorhynchus-tshawytscha Walbaum). Cell Tissue Res 248:499-503
12. Beal MF (2001) Experimental models of Parkinson's disease. Nat Rev Neurosci 2:325-334
13. Becker G, Müller A, Braune S, Büttner T, Benecke R, Greulich W, Klein W, Mark G, Rieke J, Thümler R (2002) Early diagnosis of Parkinson's disease. J Neurol 249(Suppl 3):40-48
14. Berg D, Hochstrasser H, Schweitzer KJ, Riess O (2006) Disturbance of iron metabolism in Parkinson's disease-ultrasonography as a biomarker. Neurotox Res 9:1-13
15. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-1306
16. Bezard E, Gross CE, Fournier MC, Dovero S, Bloch B, Jaber M (1999) Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Exp Neurol 155:268-273 (Pubitemid 29124720)
17. Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, Crossman AR, Bioulac B, Brotchie JM, Gross CE (2001) Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. J Neurosci 21:6853-6861 (Pubitemid 32781128)
18. Bloch A, Probst A, Bissig H, Adams H, Tolnay M (2006) Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 32:284-295
19. Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA (2010) Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain 133:1747-1754
20. Bondi MW, Kaszniak AW (1991) Implicit and explicit memory in Alzheimer's disease and Parkinson's disease. J Clin Exp Neuropsychol 13:339-358
21. Boni UD, Otvos A, Scott JW, Crapper DR (1976) Neurofibrillary degeneration induced by systemic aluminum. Acta Neuropathol 35:285-294
22. Borg-Neczak K, Tjalve H (1996) Uptake of 203Hg2+ in the olfactory system in pike. Toxicol Lett 84:107-112
23. Bosboom JL, Stoffers D, Ech Wolters (2004) Cognitive dysfunction and dementia in Parkinson's disease. J Neural Transm 111:1303-1315 (Pubitemid 39468392)
24. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318:121-134 (Pubitemid 39362633)
25. Breen EK (1993) Recall and recognition memory in Parkinson's disease. Cortex 29:91-102 (Pubitemid 23100075)
26. Brooks AI, Chadwick CA, Gelbard HA, Cory-Slechta DA, Federoff HJ (1999) Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res 823:1-10 (Pubitemid 29225488)
27. Brown RC, Lockwood AH, Sonawane BR (2006) Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect 113:1250-1256
28. Busenbark KL, Huber SJ, Greer G, Pahwa R, Koller WC (1992) Olfactory function in essential tremor. Neurology 42:1631-1632
29. Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT (2009) A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis 34:279-290
30. Cersosimo MG, Koller WC (2006) The diagnosis of manganese-induced parkinsonism. Neurotoxicology 27:340-346 (Pubitemid 44294579)
31. Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical Excellence (2006) Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5:235-245 (Pubitemid 43238347)
32. Chiueh CC, Markey SP, Burns RS, Johannessen JN, Pert A, Kopin IJ (1984) Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat. Eur J Pharmacol 100:189-194 (Pubitemid 14138269)
33. Cicchetti F, Drouin-Ouellet J, Gross RE (2009) Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? Trends Pharmacol Sci 30:475-483
34. Corasaniti MT, Strongoli MC, Rotiroti D, Bagetta G, Nisticò G (1998) Paraquat: a useful tool for the in vivo study of mechanisms of neuronal cell death. Pharmacol Toxicol 83:1-7 (Pubitemid 28386891)
35. Crapper DR, Dalton AJ (1973) Aluminum induced neurofibrillary degeneration, brain electrical activity and alterations in acquisition and retention. Physiol Behav 10:935-945
36. Crapper DR, Krishnan SS, De BU, Tomko GJ (1975) Aluminum: a possible neurotoxic agent in Alzheimer's disease. Trans Am Neurol Assoc 100:154-156
37. Crossgrove J, Zheng W (2004) Manganese toxicity upon overexposure. NMR Biomed 17:544-553 (Pubitemid 40124780)
38. Cummings JL, Masterman DL (1999) Depression in patients with Parkinson's disease. Int J Geriatr Psychiatry 14:711-718 (Pubitemid 29450282)
39. Czerniawska A (1970) Experimental investigations on penetration of 198Au from nasal mucous membrane into cerebrospinal fluid. Acta Otolaryngol 70:58-61
40. Da Cunha C, Gevaerd MS, Vital MA, Miyoshi E, Andreatini R, Silveira R, Takahashi RN, Canteras NS (2001) Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia. Behav Brain Res 124:9-18 (Pubitemid 32567554)
41. Da Cunha C, Angelucci ME, Canteras NS, Wonnacott S, Takahashi RN (2002) The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities. Cell Mol Neurobiol 22:227-237 (Pubitemid 35364882)
42. Daniel SE, Hawkes CH (1992) Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet 340:186
43. Dantzer R, Bluthe RM, Koob GF, Le Moal M (1987) Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology 91:363-368 (Pubitemid 17018107)
44. De Lorenzo AJ (1970) The olfactory neuron and the blood-brain barrier. In Ciba foundation symposium-internal secretions of the pancreas (colloquia on endocrinology), anonymous. Wiley, New York, pp 151-176
45. Dev KK, Hofele K, Barbieri S, Buchman VL, Van der Putten H (2003) Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology 45:14-44 (Pubitemid 36695009)
46. Dexter DT, Wells FR, Agid F, Agid Y, Lees AJ, Jenner P, Marsden CD (1987) Increased nigral iron content in postmortem parkinsonian brain. Lancet 2:1219-1220 (Pubitemid 17156630)
47. Di Monte DA (2003) The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol 2:531-538 (Pubitemid 36994992)
48. Di Monte D, Sandy MS, Ekström G, Smith MT (1986) Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridine (MPP+) cytotoxicity. Biochem Biophys Res Commun 137:303-309 (Pubitemid 16056066)
49. Di Monte DA, Lavasani M, Manning-Bog AB (2002) Environmental factors in Parkinson's disease. Neurotoxicology 23:487-502 (Pubitemid 36527669)
50. Diel DG, Almeida SR, Brum MC, Dezengrini R, Weiblen R, Flores EF (2007) Acute and latent infection by bovine herpesvirus type 5 in experimentally infected goats. Vet Microbiol 121:257-267 (Pubitemid 46413618)
51. Ding X, Dahl AR (2003) Olfactory mucosa: composition, enzymatic localization, and metabolism. In: Doty RL (ed) Handbook of olfaction and gustation, 2nd edn. Marcel Dekker, New York, pp 51-73
52. Dluzen DE, Kefalas G (1996) The effects of intranasal infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) upon catecholamine concentrations within olfactory bulbs and corpus striatum of male mice. Brain Res 741:215-219 (Pubitemid 26426318)
53. Dluzen DE, Muraoka S, Landgraf R (1998) Olfactory bulb norepinephrine depletion abolishes vasopressin and oxytocin preservation of social recognition responses in rats. Neurosci Lett 254:161-164 (Pubitemid 28459406)
54. Doty RL (2008) The olfactory vector hypothesis of neurodegenerative disease: is it viable? Ann Neurol 63:7-15 (Pubitemid 351240546)
55. Doty RL (2011) Role of environmental factors in Parkinson's disease. In: Aguiar AS Jr, Prediger RD (eds) Frontiers in Parkinson's disease research. Nova Science Publishers, New York, in press
56. Doty RL, Shaman P, Dann M (1984) Development of the University of Pennsylvania smell identification test: a standardized microencapsulated test of olfactory function. Physiol Behav 32:489-502 (Pubitemid 14148126)
57. Doty RL, Deems D, Stellar S (1988a) Olfactory dysfunction in Parkinson's disease: a general deficit unrelated to neurologic signs, disease state, or disease duration. Neurology 38:1237-1244
58. Doty RL, Ferguson-Segall M, Lucki I, Kreider M (1988b) Effects of intrabulbar injections of 6-hydroxydopamine on ethyl acetate odor detection in castrate and non-castrate male rats. Brain Res 444:95-103 (Pubitemid 18071199)
59. Doty RL, Singh A, Tetrude J, Langston JW (1992) Lack of olfactory dysfunction in MPTP-induced parkinsonism. Ann Neurol 32:97-100
60. Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D (1993) Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology 43:962-965 (Pubitemid 23150569)
61. Doty RL, Bromley SM, Stern MB (1995) Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration 4:93-97
62. Dubois B, Pillon B (1997) Cognitive deficits in Parkinson's disease. J Neurol 244:2-8 (Pubitemid 26413891)
63. Earle KM (1968) Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. J Neuropathol Exp Neurol 27:1-14
64. Esiri M, Tomlinson A (1984) Herpes-simplex encephalitis- immunohistological demonstration of spread of virus via olfactory and trigeminal pathways after infection of facial skin in mice. J Neurol Sci 64:213-217 (Pubitemid 14111144)
65. Evans C (2003) Vomeronasal chemoreception in vertebrates. Imperial College Press, London
66. Fall PA, Fredrikson M, Axelson O, Granérus AK (1999) Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord 14:28-37 (Pubitemid 29224673)
67. Fei Q, Ethell DW (2008) Maneb potentiates paraquat neurotoxicity by inducing key Bcl-2 family members. J Neurochem 105:2091-2097 (Pubitemid 351782244)
68. Ferro MM, Angelucci ME, Anselmo-Franci JA, Canteras NS, Da Cunha C (2007) Neuroprotective effect of ketamine/xylazine on two rat models of Parkinson's disease. Braz J Med Biol Res 40:89-96 (Pubitemid 46117723)
69. Flexner S, Clark PF (1912) A note on the mode of infection in epidemic poliomyelitis. Proc Soc Expl Biol Med 10:1-2
70. Flowers KA, Pearce I, Pearce JMS (1984) Recognition memory in Parkinson's disease. J Neurol Neurosurg Psychiatry 47:1174-1181 (Pubitemid 15204530)
71. Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55:259-272 (Pubitemid 26085575)
72. Forno LS, Langston JW, DeLanney LE, Irwin I, Ricaurte GA (1986) Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol 20(4):449-455 (Pubitemid 16005662)
73. Forno LS, DeLanney LE, Irwin I, Langston JW (1993) Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations. Adv Neurol 60:600-608
74. Franco J, Prediger RD, Pandolfo P, Takahashi RN, Farina M, Dafre AL (2007) Antioxidant responses and lipid peroxidation following intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats: increased susceptibility of olfactory bulb. Life Sci 80:1906-1914 (Pubitemid 46560734)
75. Freyaldenhoven TE, Cadet JL, Ali SF (1996) The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent. Brain Res 735:232-238 (Pubitemid 26345934)
76. Gal S, Zheng H, Fridkin M, Youdim MB (2010) Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30. Neurotox Res 17:15-27
77. Gerlach M, Riederer P (1996) Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm 103:987-1041 (Pubitemid 26383833)
78. Giovanni A, Sieber BA, Heikkila RE, Sonsalla PK (1994) Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine part 1: systemic administration. J Pharmacol Exp Ther 270:1000-1007 (Pubitemid 24315213)
79. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ (1998) The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 50:1346-1350 (Pubitemid 28240350)
80. Gorell JM, Rybicki BA, Cole JC, Peterson EL (1999) Occupational metal exposures and the risk of Parkinson's disease. Neuroepidemiology 18:303-308 (Pubitemid 29493517)
81. Goto A (1962) A long duration follow-up study of Japanese encephalitis. Folia Psychiatr Neurol Jpn 64:236-266
82. Graff CL, Pollack GM (2005) Nasal drug administration: potential for targeted central nervous system delivery. J Pharm Sci 94:1187-1195 (Pubitemid 40904183)
83. Guan X, Blank J, Dluzen DE (1993) Depletion of olfactory bulb norepinephrine by 6-OHDA disrupts chemical cue but not social recognition responses in male rats. Brain Res 622:51-57 (Pubitemid 23264946)
84. Halász N, Shepherd GM (1983) Neurochemistry of the vertebrate olfactory bulb. Neuroscience 10:579-619 (Pubitemid 14097175)
85. Halász N, Ljungdahl A, Hökfelt T, Johansson O, Goldstein M, Park D, Biberfeld P (1977) Transmitter histochemistry of the rat olfactory bulb. I. Immunohistochemical localization of monoamine synthesizing enzymes. Support for intrabulbar, periglomerular dopamine neurons. Brain Res 126:455-474 (Pubitemid 8090745)
86. Hamaue N, Ogata A, Terado M, Ohno K, Kikuchi S, Sasaki H et al (2006) Brain catecholamine alterations and pathological features with aging in Parkinson disease model rat induced by Japanese encephalitis virus. Neurochem Res 31:1451-1455 (Pubitemid 44900585)
87. Hanson LR, Frey WH 2nd (2008) Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 9:Suppl S3:S5
88. Harik SI, Schmidley JW, Iacofano LA, Blue P, Arora PK, Sayre LM (1987) On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine, its metabolite and their analogs in the rat. J Pharmacol Exp Ther 241:669-676 (Pubitemid 17111579)
89. Hasegawa E, Kang D, Sakamoto K, Mitsumoto A, Nagano T, Minakami S, Takeshige K (1997) A dual effect of 1-methyl-4-phenylpyridinium (MPP +)-analogs on the respiratory chain of bovine heart mitochondria. Arch Biochem Biophys 337:69-74 (Pubitemid 27198056)
90. Hastings L, Evans JE (1988) Transaxonal transport of cadmium in the olfactory system. Chem Senses 13:696
91. Hastings L, Evans JE (1991) Olfactory primary neurons as a route of entry for toxic agents into the CNS. Neurotoxicology 12:707-714
92. Hastings TG, Lewis DA, Zigmond MJ (1996) Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease. Adv Exp Med Biol 387:97-106 (Pubitemid 26259234)
93. Hawkes CH, Doty RL (2009) The neurology of olfaction. Cambridge University Press, Cambridge
94. Hawkes CH, Shephard BC (1993) Selective anosmia in Parkinson's disease? Lancet 341:435-436
95. Hawkes CH, Shephard BC, Daniel SE (1999) Is Parkinson's disease a primary olfactory disorder? QJM 92:473-480 (Pubitemid 29385293)
96. Hawkes CH, Del Tredici K, Braak H (2007) Parkinson's disease: a dual hit hypothesis. Neuropathol Appl Neurobiol 33:599-614 (Pubitemid 350076090)
97. Hayek R, Waite PME (1991) The olfactory pathway as a possible route for aluminum entry to the brain. J Neurochem 57:S113
98. He Y, Imam SZ, Dong Z, Jankovic J, Ali SF, Appel SH, Le W (2003) Role of nitric oxide in rotenone-induced nigro-striatal injury. J Neurochem 86:1338-1345 (Pubitemid 37174251)
99. Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC (1985) Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine toxicity. Neurosci Lett 62:389-394 (Pubitemid 16147750)
100. Henriksson J, Tjalve H (1998) Uptake of inorganic mercury in the olfactory bulbs via olfactory pathways in rats. Environ Res 77:130-140 (Pubitemid 28243887)
101. Henriksson J, Tjälve H (2000) Manganese taken up into the CNS via the olfactory pathway in rats affects astrocytes. Toxicol Sci 55:392-398 (Pubitemid 30353248)
102. Henriksson J, Tallkvist J, Tjalve H (1999) Transport of manganese via the olfactory pathway in rats: dosage dependency of the uptake and subcellular distribution of the metal in the olfactory epithelium and the brain. Toxicol Appl Pharmacol 156:119-128 (Pubitemid 29196575)
103. Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopamine neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334:345-348
104. Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J Neurochem 56:446-451 (Pubitemid 21901982)
105. Inden M, Kitamura Y, Takeuchi H, Yanagida T, Takata K, Kobayashi Y, Taniguchi T, Yoshimoto K, Kaneko M, Okuma Y, Taira T, Ariga H, Shimohama S (2007) Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. J Neurochem 101:1491-1504 (Pubitemid 46848844)
106. Jang H, Boltz D, Sturm-Ramierz K, Shepherd KR, Jian Y, Webster R, Smeyne RJ (2009) Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci USA 106:14063-14068
107. Johnson CC, Gorell JM, Rybicki BA, Sanders K, Peterson EL (1999) Adult nutrient intake as a risk factor for Parkinson's disease. Int J Epidemiol 28:1102-1109 (Pubitemid 30021310)
108. Jonsson G, Sachs C (1975) Actions of 6-hydroxydopamine quinones on catecholamine neurons. J Neurochem 25:509-516
109. Kalaria RN, Mitchell MJ, Harik SI (1987) Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity. Proc Natl Acad Sci USA 84:3521-3525 (Pubitemid 17085436)
110. Kamel F, Tanner C, Umbach D, Hoppin J, Alavanja M, Blair A, Comyns K, Goldman S, Korell M, Langston J, Ross G, Sandler D (2007) Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am J Epidemiol 165:364-374
111. Kawano T, Margolis FL (1982) Transsynaptic regulation of olfactory bulb catecholamines in mice and rats. J Neurochem 39:342-348 (Pubitemid 12013611)
112. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-608 (Pubitemid 28207717)
113. Koutsilieri E, Sopper S, Scheller C, Ter MV, Riederer P (2002) Parkinsonism in HIV dementia. J Neural Transm 109:767-775 (Pubitemid 34810772)
114. Lafay F, Coulon P, Astic L, Saucier D, Riche D, Holley A, Flamand A (1991) Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation. Virology 183:320-330
115. Lan J, Jiang DH (1997) Excessive iron accumulation in the brain: a possible potential risk of neurodegeneration in Parkinson's disease. J Neural Transm 104:649-660 (Pubitemid 27474679)
116. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980 (Pubitemid 13189531)
117. Levenson CW, Cutler RG, Ladenheim B, Cadet JL, Hare J, Mattson MP (2004) Role of dietary iron restriction in a mouse model of Parkinson's disease. Exp Neurol 190:506-514 (Pubitemid 39505004)
118. Lewis SJG, Dove A, Robbins TW, Barker RA, Owen AM (2003) Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 23:6351-6356 (Pubitemid 36875637)
119. Lewy FH (1912) Paralysis agitans. Pathologische Anatomie. In: Lewandowski M (ed) Handbuch der Neurologie. Springer, Berlin Heidelberg New York, pp 920-933
120. Lucchini RG, Martin CJ, Doney BC (2009) From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure. Neuromolecular Med 11:311-332
121. Lundh B, Love A, Kristensson K, Norrby E (1988) Non-lethal infection of aminergic reticular core neurons: age-dependent spread of ts mutant vesicular stomatitis virus from the nose. J Neuropathol Exp Neurol 47:497-506
122. Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA (2002) The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 277:1641-1644 (Pubitemid 34968732)
123. Marttila RJ, Rinne UK (1978) Herpes simplex virus antibodies in patients with Parkinson's disease. J Neurol Sci 35:375-379 (Pubitemid 8282573)
124. Marttila RJ, Arstila P, Nikoskelainen J, Halonen PE, Rinne UK (1977) Viral antibodies in the sera from patients with Parkinson disease. Eur Neurol 15:25-33 (Pubitemid 8078920)
125. Marttila RJ, Rinne UK, Halonen P, Madden DL, Sever JL (1981) Herpesviruses and parkinsonism Herpes simplex virus types 1 and 2, and cytomegalovirus antibodies in serum and CSF. Arch Neurol 38:19-21 (Pubitemid 11213521)
126. Martyn CN (1997) Infection in childhood and neurological diseases in adult life. Br Med Bull 53:24-39 (Pubitemid 27129175)
127. Martyn CN, Osmond C (1995) Parkinson's disease and the environment in early life. J Neurol Sci 132:201-206
128. Mayeux R (2003) Epidemiology of neurodegeneration. Annu Rev Neurosci 26:81-104 (Pubitemid 37064929)
129. Meissner W, Hill MO, Tison F, Gross CE, Bezard E (2004) Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials. Trends Pharmacol Sci 25:249-253 (Pubitemid 38553826)
130. Menco BPH, Morrison EE (2003) Morphology of the mammalian olfactory epithelium: form, fine structure, function, and pathology. In: Doty RL (ed) Handbook of olfaction and gustation, 2nd edn. Marcel Dekker, New York, pp 17-49
131. Meredith M (2001) Human vomeronasal organ function: a critical review of best and worst cases. Chem Senses 26:433-445 (Pubitemid 32454793)
132. Merkus FW, Van den Berg MP (2007) Can nasal drug delivery bypass the blood-brain barrier?: questioning the direct transport theory. Drugs R D 8:133-144 (Pubitemid 46707837)
133. Misra UK, Kalita J, Pandey S, Khanna VK, Babu GN (2005) Cerebrospinal fluid catecholamine levels in Japanese encephalitis patients with movement disorders. Neurochem Res 30:1075-1078 (Pubitemid 41642148)
134. Monath T, Cropp C, Harrison A (1983) Mode of entry of a neurotropic arbovirus into the central nervous system-reinvestigation of an old controversy. Lab Invest 48:399-410 (Pubitemid 13119063)
135. Monnet-Tschudi F, Zurich MG, Boschat C, Corbaz A, Honegger P (2006) Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases. Rev Environ Health 21:105-117 (Pubitemid 44077520)
136. Moore G (1977) Influenza and Parkinson's disease. Public Health Rep 92:79-80 (Pubitemid 8128171)
137. Morales JA, Herzog S, Kompter C, Frese K, Rott R (1988) Axonal transport of Borna disease virus along olfactory pathways in spontaneously and experimentally infected rats. Med Microbiol Immunol 177:51-68 (Pubitemid 18057798)
138. Moreira EL, Rial D, Aguiar AS Jr, Figueiredo CP, Siqueira JM, DalBó S, Horst H, de Oliveira J, Mancini G, dos Santos TS, Villarinho JG, Pinheiro FV, Marino-Neto J, Ferreira J, De Bem AF, Latini A, Pizzolatti MG, Ribeiro-do-Valle RM, Prediger RD (2010) Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease. J Neural Transm 117:1337-1351
139. Mori I, Komatsu T, Takeuchi K, Nakakuki K, Sudo M, Kimura Y (1995) Parainfluenza virus type-1 infects olfactory neurons and establishes long-term persistence in the nerve-tissue. J Gen Virol 76:1251-1254
140. Morris RG, Garrud P, Rawlins JN, O'keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297:681-683 (Pubitemid 12096189)
141. Mulder W, Pol J, Kimman T, Kok G, Priem J, Peeters B (1996) Glycoprotein D-negative pseudorabies virus can spread transneuronally via direct neuron-to-neuron transmission in its natural host, the pig, but not after additional inactivation of gE or gI. J Virol 70:2191-2200 (Pubitemid 26087579)
142. Murgod UA, Muthane UB, Ravi V, Radhesh S, Desai A (2001) Persistent movement disorders following Japanese encephalitis. Neurology 57:2313-2315 (Pubitemid 34016472)
143. Narita M, Uchimura A, Kawanabe M, Fukushi H, Hirai K (2001) Invasion and spread of equine herpesvirus 9 in the olfactory pathway of pigs after intranasal inoculation. J Comp Pathol 124:265-272 (Pubitemid 32631561)
144. O'Brien JA, Ward A, Michels SL, Tzivelekis S, Brandt NJ (2003) Economic burden associated with Parkinson disease. Drug Benefit Trends 21:179-190
145. Ogata A, Tashiro K, Nukuzuma S, Nagashima K, Hall WW (1997) A rat model of Parkinson's disease induced by Japanese encephalitis virus. J Neurovirol 3:141-147 (Pubitemid 27182507)
146. Ogata A, Tashiro K, Pradhan S (2000) Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. Neurology 55:602 (Pubitemid 30647273)
147. Olanow CW (2007) The pathogenesis of cell death in Parkinson's disease. Mov Disord Suppl 17:S335-S342
148. Oliver KR, Fazakerley J (1998) Transneuronal spread of Semliki Forest virus in the developing mouse olfactory system is determined by neuronal maturity RID A-7352-2008. Neuroscience 82:867-877 (Pubitemid 27479624)
149. Oliver KR, Scallan MF, Dyson H, Fazakerley JK (1997) Susceptibility to a neurotropic virus and its changing distribution in the developing brain is a function of CNS maturity. J Neurovirol 3:38-48 (Pubitemid 27085130)
150. Owen AM, Iddon JL, Hodges JR, Summers BA, Robbins TW (1997) Spatial and non-spatial working memory at different stages of Parkinson's disease. Neuropsychologia 35:519-532 (Pubitemid 27144004)
151. Packard MG, Knowlton BJ (2002) Learning and memory functions of the basal ganglia. Annu Rev Neurosci 25:563-593 (Pubitemid 34748029)
152. Pardridge WM (1997) Drug delivery to the brain. J Cereb Blood Metab 17:713-731 (Pubitemid 27427575)
153. Passingham D, Sakai K (2004) The prefrontal cortex and working memory: physiology and brain imaging. Curr Opin Neurobiol 14:163-168 (Pubitemid 38479932)
154. Perl D, Good P (1987) Uptake of aluminum into central nervous system along nasal-olfactory pathways. Lancet 1:1028 (Pubitemid 17057868)
155. Perl DP, Olanow CW (2007) The neuropathology of manganese-induced parkinsonism. J Neuropathol Exp Neurol 66:675-682 (Pubitemid 47344246)
156. Persson E, Henriksson J, Tallkvist J, Rouleau C, Tjalve H (2003) Transport and subcellular distribution of intranasally administered zinc in the olfactory system of rats and pikes. Toxicology 191:97-108 (Pubitemid 37336536)
157. Petroske E, Meredith GE, Callen S, Totterdell S, Lau YS (2001) Mouse model of parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment. Neuroscience 106:589-601 (Pubitemid 32925247)
158. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047 (Pubitemid 27443610)
159. Poser CM, Huntley CJ, Poland JD (1969) Para-encephalitic parkinsonism report of an acute case due to coxsackie virus type B 2 and re-examination of the etiologic concepts of postencephalitic parkinsonism. Acta Neurol Scand 45:199-215
160. Poskanzer DC, Schwab RS (1963) Cohort analysis of Parkinson's syndrome: evidence for a single etiology related to subclinical infection about 1920. J Chronic Dis 16:961-973
161. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H (2003) Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 60:1761-1766 (Pubitemid 36737070)
162. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H (2009) Dietary fats, cholesterol and iron as risk factors for Parkinson's disease. Parkinsonism Relat Disord 15:47-52
163. Pranzatelli MR, Mott SH, Pavlakis SG, Conry JA, Tate ED (1994) Clinical spectrum of secondary parkinsonism in childhood: a reversible disorder. Pediatr Neurol 10:131-140 (Pubitemid 24113315)
164. Prediger RD, Batista LC, Medeiros R, Pandolfo P, Florio JC, Takahashi RN (2006) The risk is in the air: intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease. Exp Neurol 202:391-403 (Pubitemid 44692682)
165. Prediger RD, Rial D, Medeiros R, Figueiredo CP, Doty RL, Takahashi RN (2009a) Risk is in the air: an intranasal MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) rat model of Parkinson's disease. Ann N Y Acad Sci 1170:629-636
166. Prediger RD, Rial D, Medeiros R, Figueiredo CP, Doty RL, Takahashi RN (2009b) Risk is in the air: an intranasal MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) rat model of Parkinson's disease. Ann N Y Acad Sci 1170:629-636
167. Prediger RD, Aguiar AS Jr, Rojas-Mayorquin AE, Figueiredo CP, Matheus FC, Ginestet L, Chevarin C, Bel ED, Mongeau R, Hamon M, Lanfumey L, Raisman-Vozari R (2010) Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease. Neurotox Res 17:114-129
168. Prediger RD, Aguiar AS Jr, Moreira EL, Matheus FC, Castro AA, Walz R, De Bem AF, Latini A, Tasca CI, Farina M, Raisman-Vozari R (2011) The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease. Curr Pharm Des 17:489-507
169. Reiss C, Plakhov I, Komatsu T (1998) Viral replication in olfactory receptor neurons and entry into the olfactory bulb and brain. In: Olfaction and taste XII: an international symposium, vol 855, pp 751-761 (Pubitemid 29110067)
170. Richardson JR, Quan Y, Sherer TB, Greenamyre JT, Miller GW (2005) Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci 88:193-201 (Pubitemid 41548761)
171. Riederer P, Wuketich S (1976) Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm 38:277-301
172. Rieger B, Markowitsch HJ (1996) Implicit and explicit mnestic performance of patients with prefrontal, medial temporal, and basal ganglia damage. Neurol Psychiatry Brain Res 4:53-74 (Pubitemid 26344730)
173. Roberts J (1962) Histopathogenesis of Mousepox. I. Respiratory Infection. Br J Exp Pathol 43:451-461
174. Robinson RL, Shahida S, Madan N, Rao S, Khardori N (2003) Transient parkinsonism in West Nile virus encephalitis. Am J Med 115:252-253 (Pubitemid 37338156)
175. Rojo AI, Montero C, Salazar M, Close RM, Fernández-Ruiz J, Sánchez-González MA, de Sagarra MR, Jackson-Lewis V, Cavada C, Cuadrado A (2006) Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice. Eur J Neurosci 24:1874-1884 (Pubitemid 44583472)
176. Rojo AI, Cavada C, de Sagarra MR, Cuadrado A (2007) Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats. Exp Neurol 208:120-126 (Pubitemid 47600154)
177. Ross CA, Smith WW (2007) Gene-environment interactions in Parkinson's disease. Parkinsonism Relat Disord Suppl 13:S309-S315
178. Royet JP, Gervais R, Araneda S (1983) Effect of local 6-OHDA and 5,6-DHT injections into the rat olfactory bulb on neophobia and learned aversion to a novel food. Behav Brain Res 10:297-309 (Pubitemid 14216748)
179. Rudd PA, Cattaneo R, von Messling V (2006) Canine distemper virus uses both the anterograde and the hematogenous pathway for neuroinvasion. J Virol 80:9361-9370 (Pubitemid 44435615)
180. Ryzhikov A, Ryabchikova E, Sergeev A, Tkacheva N (1995) Spread of Venezuelan equine encephalitis virus in mice olfactory tract. Arch Virol 140:2243-2254 (Pubitemid 3020065)
181. Salazar J, Mena N, Hunot S, Prigent A, Alvarez-Fischer D, Arredondo M, Duyckaerts C, Sazdovitch V, Zhao L, Garrick LM, Nunez MT, Garrick MD, Raisman-Vozari R, Hirsch EC (2008) Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc Nat Acad Sci USA 105:18578-18583
182. Santin R, Fonseca VF, Bleil CB, Rieder CR, Hilbig A (2010) Olfactory function and Parkinson's disease in Southern Brazil. Arq Neuropsiquiatr 68:252-257
183. Sasco AJ, Paffenbarger RS (1985) Measles infection and Parkinson's disease. Am J Epidemiol 122:1017-1031 (Pubitemid 16170037)
184. Sauer H, Oertel WH (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59:401-415 (Pubitemid 24098798)
185. Schapira AH (2008) Neurobiology and treatment of Parkinson's disease. Trends Pharmacol Sci 30:41-47
186. Schapira AH, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 55:2142-2145 (Pubitemid 120021853)
187. Schmidt N, Ferger B (2001) Neurochemical findings in the MPTP model of Parkinson's disease. J Neural Transm 108:1263-1282 (Pubitemid 33141302)
188. Schuler F, Casida JE (2001) The insecticide target in the PSST subunit of complex I. Pest Manag Sci 57:932-940 (Pubitemid 32979914)
189. Sedelis M, Hofele K, Auburger GW, Morgan S, Huston JP, Schwarting RK (2000) MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences. Behav Genet 30:171-182
190. Semchuk KM, Love EJ, Lee RG (1992) Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 42:1328-1335
191. Sherer TB, Kim JH, Betarbet R, Greenamyre JT (2003) Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 179:9-16 (Pubitemid 36062614)
192. Shimizu K, Ohtaki K, Matsubara K, Aoyama K, Uezono T, Saito O, Suno M, Ogawa K, Hayase N, Kimura K, Shiono H (2001) Carrier-mediated processes in blood-brain barrier penetration and neural uptake of paraquat. Brain Res 906:135-142 (Pubitemid 32595547)
193. Shipley MT, Halloran FJ, de la Torre J (1985) Surprisingly rich projection from locus coeruleus to the olfactory bulb in the rat. Brain Res 329:294-299 (Pubitemid 15141303)
194. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839-840
195. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci USA 95:6469-6473 (Pubitemid 28249037)
196. Stebbins GT, Gabrieli JD, Masciari F, Monti L, Goetz CG (1999) Delayed recognition memory in Parkinson's disease: a role for working memory? Neuropsychologia 37:503-510 (Pubitemid 29138933)
197. Stephenson R, Houghton D, Sundarararjan S, Doty RL, Stern M, Xie SX, Siderowf A (2010) Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease. Mov Disord 25:2099-2104
198. Stroop W, Rock D, Fraser N (1984) Localization of herpes simplex virus in the trigeminal and olfactory systems of the mouse central nervous system during acute and latent infections by insitu hybridization. Lab Invest 51:27-38 (Pubitemid 14053751)
199. Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ (2006) Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 66:968-975 (Pubitemid 44044778)
200. Takahashi N, Miner LL, Sora I, Ujike H, Revay RS, Kostic V, Jackson-Lewis V, Przedborski S, Uhl GR (1997) VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci USA 94:9938-9943
201. Tallkvist J, Henriksson J, d'Argy R, Tjalve H (1998) Transport and subcellular distribution of nickel in the olfactory system of pikes and rats. Toxicol Sci 43:196-203 (Pubitemid 28363393)
202. Tallkvist J, Persson E, Henriksson J, Tjalve H (2002) Cadmium-metallothionein interactions in the olfactory pathways of rats and pikes. Toxicol Sci 67:108-113 (Pubitemid 34520816)
203. Tanner CM (1989) The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci 12:49-54 (Pubitemid 19054583)
204. Tanner CM (2010) Advances in environmental epidemiology. Mov Disord 25(Suppl 1):S58-S62
205. Thiruchelvam M, Brockel BJ, Richfield EK, Baggs RB, Cory-Slechta DA (2000a) Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Res 873:225-234 (Pubitemid 30619046)
206. Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA (2000b) The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J Neurosci 20:9207-9214 (Pubitemid 32042923)
207. Thiruchelvam M, Richfield EK, Goodman BM, Baggs RB, Cory-Slechta DA (2002) Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 23:621-633 (Pubitemid 36527682)
208. Thiruchelvam M, McCormack A, Richfield EK, Baggs RB, Tank AW, Di Monte DA, Cory-Slechta DA (2003) Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur J Neurosci 18:589-600 (Pubitemid 37045378)
209. Thompson K, Molina RM, Donaghey T, Schwob JE, Brain JD, Wessling-Resnick M (2007) Olfactory uptake of manganese requires DMT1 and is enhanced by anemia. FASEB J 21:223-230 (Pubitemid 46052560)
210. Thor DH, Holloway WR (1982) Social memory of the male laboratory rat. J Comp Physiol Psychol 96:1000-1006
211. Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, Wolters EC (2001) Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord 16:41-46 (Pubitemid 36041112)
212. Tjalve H, Mejare C, Borg-Neczak K (1995) Uptake and transport of manganese in primary and secondary olfactory neurones in pike. Pharmacol Toxicol 77:23-31
213. Tolosa E, Compta Y, Gaig C (2007) The premotor phase of Parkinson's disease. Parkinsonism Relat Disord 13(Suppl):S2-S7
214. Ungerstedt U (1968) 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5:107-110
215. Uversky VN (2004) Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res 318:225-241 (Pubitemid 39362642)
216. Vanacore N, Nappo A, Gentile M, Brustolin A, Palange S, Liberati A, Di Rezze S, Caldora G, Gasparini M, Benedetti F, Bonifati V, Forastiere F, Quercia A, Meco G (2002) Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users. Neurol Sci 23(Suppl 2):S119-S120
217. Varastet M, Riche D, Maziere M, Hantraye P (1994) Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease. Neuroscience 63:47-56
218. Vila M, Przedborski S (2003) Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci 4:365-375 (Pubitemid 37280175)
219. Wang XF, Li S, Chou AP, Bronstein JM (2006) Inhibitory effects of pesticides on proteasome activity: implication in Parkinson's disease. Neurobiol Dis 23:198-205 (Pubitemid 43903639)
220. Wang B, Feng WY, Wang M, Shi JW, Zhang F, Ouyang H, Zhao YL, Chai ZF, Huang YY, Xie YN, Wang HF, Wang J (2007) Transport of intranasally instilled fine Fe2O3 particles into the brain: micro-distribution, chemical states, and histopathological observation RID B-1461-2009. Biol Trace Elem Res 118:233-243 (Pubitemid 47556621)
221. Ward CD, Hess WA, Calne DB (1983) Olfactory impairment in Parkinson's disease. Neurology 33:943-946 (Pubitemid 13066700)
222. White NM, McDonald RJ (2002) Multiple parallel memory systems in the brain of the rat. Neurobiol Learn Mem 77:125-184 (Pubitemid 34971650)
223. Wright JM, Wall RA, Perry TL, Paty DW (1984) Chronic parkinsonism secondary to intranasal administration of a product of meperidine-analogue synthesis. N Engl J Med 310:325
224. Wu H, Hu K, Jiang X (2008) From nose to brain: understanding transport capacity and transport rate of drugs. Expert Opin Drug Deliv 5:1159-1168
225. Yasui M, Kihira T, Ota K (1992) Calcium, magnesium and aluminum concentrations in Parkinson's disease. Neurotoxicology 13:593-600
226. Youdim MB, Ben-Shachar D, Riederer P (1993) The possible role of iron in the etiopathology of Parkinson's disease. Mov Disord 8:1-12 (Pubitemid 23039223)
227. Zatta P, Favarato M, Nicolini M (1993) Deposition of aluminum in brain-tissues of rats exposed to inhalation of aluminum acetylacetonate. Neuroreport 4:1119-1122 (Pubitemid 23251700)
228. Zhao H, Otaki J, Firestein S (1996) Adenovirus-mediated gene transfer in olfactory neurons in vivo. J Neurobiol 30:521-530 (Pubitemid 26256775)